- 84% of the population is now advised annual vaccinations
- All children 6 months through 18 years of age are advised annual vaccinations
- Vaccination is recommended for “All persons who want to reduce the risk of becoming ill with influenza or of transmitting it to others”
- Vaccine last year was 44% effective
- An oculorespiratory syndrome, typically mild, has been linked to influenza vaccination, and it may or may not recur upon subsequent flu vaccinations; its pathogenesis is uncertain
- The flu vaccine for the 2009-10 season will contain the same H3N2 and H1N1 (NOT the swine H1N1) antigens as were in the past year's vaccine, but will have a new influenza B component
- Most flu last year was H1N1, and all tested H1N1 strains were resistant to Tamiflu, but sensitive to adamantanes. Tested H3N2 and Influenza B strains were sensitive to both Tamiflu and Zanamivir.
This blog began in 2007, focusing on anthrax vaccine, and later expanded to other public health and political issues. The blog links to media reports, medical literature, official documents and other materials.
Sunday, July 19, 2009
CDC's influenza vaccine for seasonal (non-pandemic) influenza, 2009-10
Useful facts regarding the standard (non-swine) flu vaccine: advice from CDC:
No comments:
Post a Comment